Merck Sharp & Dohme LLC v. The Johns Hopkins University
Case Number:
1:22-cv-03059
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
June 10, 2025
Merck Gets PTAB To Nix Johns Hopkins Cancer Drug Patent
Merck & Co. Inc. subsidiary Merck Sharp & Dohme LLC has notched a win at the Patent Trial and Appeal Board in its disagreement with Johns Hopkins University over a cancer research partnership, persuading a panel to invalidate claims in a university-owned patent relating to a colorectal cancer treatment.
-
November 29, 2022
Johns Hopkins Breached Keytruda Deal, Merck Sharp Says
Merck Sharp took Johns Hopkins University to federal court in Maryland on Tuesday over claims that the university secretly obtained patents for inventions based on a collaborative clinical study treating cancer patients with Merck Sharp's Keytruda drug and funding, and then licensing the patents to others in violation of their contract.